MNTA/Lovenox update from AMPH’s 3Q15 CC: AMPH is now boasting that it has “strong defenses” in the Lovenox patent trial that has been remanded to the US District Court (#msg-118404904); however, AMPH’s executives are no longer talking about collecting on NVS/MNTA’s $100M District Court bond that has been held by the Court since Oct 2011, pending a final outcome in the patent case.
This is a big change from AMPH’s previous CCs.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.